Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Cryptococcosis Treatment

    ... at a CAGR of 4.5% over the analysis period 2023-2030. Amphotericin B Treatment, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$5.5 Billion by the end ... Read More

  • Extracorporeal CO2 Removal Devices

    ... reach US$151.9 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Extracorporeal CO2 Machines, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and ... Read More

  • Intrauterine Insemination

    ... at a CAGR of 7.9% over the analysis period 2023-2030. The U.S. Market is Estimated at US$441.0 Million While China is Forecast to Grow at 11.5% CAGR The Intrauterine Insemination market in the U.S. is ... Read More

  • Acute Repetitive Seizures

    ... by 2030, growing at a CAGR of 44.7% over the analysis period 2023-2030. Diastat Rectal Gel, one of the segments analyzed in the report, is expected to record a 46.2% CAGR and reach US$8.4 Billion ... Read More

  • Hyperpigmentation Disorders Treatment

    ... by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by ... Read More

  • Neuroprotection Therapeutics

    ... at a CAGR of 6.9% over the analysis period 2023-2030. Free Radical Trapping Agents (Antioxidants), one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$45.7 Billion by ... Read More

  • Patient Monitoring Devices

    ... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More

  • Prosthetics and Orthotics

    ... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Orthotics, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$7.5 Billion by the ... Read More

  • Sarcoma Drugs

    ... at a CAGR of 7.5% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.9 Billion by the end of ... Read More

  • Cutaneous T-cell lymphoma - Pipeline Insight, 2024

    ... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More

  • Lou Gehrig’s disease - Pipeline Insight, 2024

    ... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More

  • Orthopedic Bone Cement

    ... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$944.8 ... Read More

  • Restorative Dentistry

    ... at a CAGR of 8.3% over the analysis period 2023-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$19.4 Billion by the end of ... Read More

  • Veterinary Orthopedics

    ... at a CAGR of 8.2% over the analysis period 2023-2030. Veterinary Orthopedics Implants, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$768.3 Million by the end ... Read More

  • Glioblastoma Multiforme Treatment (GBM)

    ... reach US$4.8 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Radiation Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More

  • Hematological Malignancies

    ... at a CAGR of 6.2% over the analysis period 2023-2030. Leukemia Disease, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$33.3 Billion by the end of ... Read More

  • Ligament Stabilizers

    ... at a CAGR of 4.6% over the analysis period 2023-2030. Grade 1 Injury Stabilizers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.0 Billion by the ... Read More

  • Nephrology And Urology Devices

    ... reach US$39.3 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Dialysis Devices, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach ... Read More

  • Connected Care in North America 3rd Edition

    ... and remote patient monitoring (RPM) markets in thisregion. This strategic research report from Berg Insight providesyou with 150 pages of unique business intelligence including 5-yearindustry forecasts and expert commentary on which to base yourbusiness decisions. Read More

  • Hospital Acquired Infection Treatment

    ... reach US$45.5 Billion by 2030, growing at a CAGR of 2.7% over the analysis period 2023-2030. Urinary Tract Infections, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and ... Read More

  • Ophthalmic Ultrasound Systems

    ... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Portable Systems, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by ... Read More

  • Radiodermatitis

    ... of 4.2% over the analysis period 2023-2030. Topical Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$412.0 Million by the end of the analysis period. ... Read More

  • Veterinary Oncology

    ... at a CAGR of 10.7% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 11.8% CAGR and reach US$246.0 Million by the end of the ... Read More

  • Artificial Tendons and Ligaments

    ... reach US$75.1 Million by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. Knee Injuries Application, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and ... Read More

  • Orthopedic Soft Tissue Repair

    ... reach US$12.1 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Cruciate Ligaments Repair Procedure, one of the segments analyzed in the report, is expected to record a 7.0% CAGR ... Read More

Cookie Settings